
Sign up to save your podcasts
Or


Heart failure with preserved ejection fraction (HFpEF) poses a significant challenge because of its heterogeneous nature and the scarcity of therapies that meaningfully alter its course. The SUMMIT study evaluated the impact of tirzepatide on symptoms and mortality in people with HFpEF and obesity.
Guests: Jennifer N. Clements, Pharm.D., FCCP, FADCES, BCPS, BCACP, BC-ADM, CDCES and Dawn C. Fuke, Pharm.D., BCPS, BCACP
Music by Good Talk
By University of Mississippi School of Pharmacy4.9
3434 ratings
Heart failure with preserved ejection fraction (HFpEF) poses a significant challenge because of its heterogeneous nature and the scarcity of therapies that meaningfully alter its course. The SUMMIT study evaluated the impact of tirzepatide on symptoms and mortality in people with HFpEF and obesity.
Guests: Jennifer N. Clements, Pharm.D., FCCP, FADCES, BCPS, BCACP, BC-ADM, CDCES and Dawn C. Fuke, Pharm.D., BCPS, BCACP
Music by Good Talk

78,320 Listeners

30,693 Listeners

14,369 Listeners

502 Listeners

101 Listeners

883 Listeners

3,363 Listeners

112,880 Listeners

56,546 Listeners

1,153 Listeners

16,924 Listeners

732 Listeners

25,347 Listeners

166 Listeners

288 Listeners